Table 1 Characteristic of patients in AMRT + and AMRT- group
Group | AMRT+ (N = 44) a | AMRT- (N = 69) a | P-value |
|---|---|---|---|
Gender-boy, n (%) | 25 (56.82%) | 41 (59.42%) | 0.7844 |
Age, mean ± SD | 80.34 ± 55.10 | 71.20 ± 50.07 | 0.4119 |
Immunosuppression, n (%) | 22 (50%) | 20 (28.99%) | 0.0242 |
Underlying disease, n (%) | 31 (70.45%) | 28 (40.58%) | 0.0019 |
Leukemia, n (%) | 17 (38.64%) | 12 (17.39%) | 0.0117 |
Symptoms | |||
Fever, n (%) | 42 (95.45%) | 59 (85.51%) | 0.0942 |
Cough, n (%) | 17 (38.64%) | 15 (21.74%) | 0.0519 |
Clinical feature, mean ± SD | |||
BMI | 14.80 ± 2.58 | 16.12 ± 3.53 | 0.0411 |
pSOFA | 5.27 ± 3.31 | 4.1 ± 2.89 | 0.0466 |
PRISM | 12.39 ± 10.23 | 4.81 ± 5.67 | < 0.0001 |
PCIS | 85.77 ± 7.75 | 88.75 ± 8.62 | 0.0405 |
WBC | 8.33 ± 9.17 | 12.12 ± 30.43 | 0.4042 |
NEUT | 7.18 ± 7.18 (n = 39) | 6.41 ± 5.8 (n = 66) | 0.6677 |
LY | 1.36 ± 1.72 (n = 39) | 1.69 ± 1.92 (n = 66) | 0.3990 |
NEUT% | 69.56 ± 22.53 (n = 39) | 65.39 ± 22 (n = 67) | 0.4120 |
LY% | 30.53 ± 70.20 (n = 39) | 24.84 ± 18.12 (n = 67) | 0.4887 |
PLT | 173.27 ± 161.87 | 212.32 ± 164.9 | 0.2195 |
HBG | 111.45 ± 121.47 | 107.07 ± 20.59 | 0.7715 |
BUN | 4.93 ± 3.53 | 4.93 ± 3.79 | 0.9183 |
Cr | 24.77 ± 12.13 | 42.61 ± 72.66 | 0.0975 |
TBIL | 20.09 ± 27.42 | 12.93 ± 18.34 | 0.2055 |
PaO2/FiO2 | 269.23 ± 135.18 | 306.73 ± 132.25 | 0.1618 |
CRP | 67.69 ± 80.16 | 29.18 ± 46 | 0.0025 |
PCT | 10.83 ± 27.49 | 9.82 ± 50.56 (n = 67) | 0.9259 |
γ-IFN | 5.78 ± 6.24 | 184.34 ± 987.38 (n = 66) | 0.2392 |
IL-6 | 728.61 ± 1783.29 (n = 40) | 646.32 ± 2934.9 (n = 66) | 0.9581 |
IL-10 | 360.54 ± 990.91 | 291.14 ± 1611.67 (n = 66) | 0.7807 |
LOHS, mean ± SD | 48.7 ± 43.39 | 16.46 ± 12.11 | < 0.0001 |
ICU, mean ± SD | 23.05 ± 31.89 | 8.72 ± 7.83 | 0.0005 |
Mortality rate, n (%) | 8 (18.18%) | 7 (10.14%) | 0.2195 |